$4.41
-0.17-3.71%
At close: -
$4.19
-0.22-4.99%
After Hours: Dec 20, 4:34 PM EDT
ImmuCell reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of ImmuCell using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2021 | 2021-05-13 | $-0.06 | $0.05 | -220.0 % |
Sep 2020 | 2020-11-12 | $-0.04 | $-0.08 | 50.0 % |
Jun 2020 | 2020-08-12 | $-0.11 | $-0.10 | -10.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-13 | $5.47M | $3.26M | 67.9 % |
Sep 2022 | 2022-11-21 | $4.80M | $5.40M | -11.2 % |
Mar 2022 | 2022-05-12 | $6.00M | $5.40M | 11.1 % |
Dec 2021 | 2022-02-22 | $5.44M | $5.40M | 0.81 % |
ImmuCell (ICCC) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.09, which missed the estimate of $0.00.
The Actual Revenue was $6M, which beat the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.